Concepedia

Author

Jennifer Hill

University of OxfordORCID

Also Known As

J. Hill, Jennifer Hill, Jennifer W Hill, Julius Asante-Siaw, Maheshwar Ghimire, Mwila Kasanyinga, Sophia Hawkins

74

Publications

14.8K

Citations

30

H-Index

59

Concepts

All Affiliations

University of OxfordOxford BioMedica (United Kingdom)University College LondonUniversity of SheffieldUniversity of Liverpool
JH

About

Jennifer Hill is an author at University of Oxford specializing in medicine, immunology, and autoimmunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

3.5K

2

Biochemistry

2

2

94

3

Health Sciences

1

1

138

4

Natural Sciences

1

1

41

5

Public Health

1

1

35

Jennifer Hill

×

37

Publications

13.2K

Citations

25

H-Index

YearCitations

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi,

The Lancet

2020

5K

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley,

The Lancet

2020

2.6K

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

Nicholas McGranahan, Rachel Rosenthal, Crispin T. Hiley,

Cell

2017

1.3K

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi,

The Lancet

2021

1.2K

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

Frederick Arce Vargas, Andrew J.S. Furness, Isabelle Solomon,

Immunity

2017

425

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

Mark Ainsworth, Monique Andersson, Kathryn Auckland,

The Lancet Infectious Diseases

2020

397

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Christina Dold,

Nature Medicine

2020

334

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

David Ahern, Zhichao Ai, Mark Ainsworth,

Cell

2022

319

Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial

Celina Jin, Malick M. Gibani, Maria Moore,

The Lancet

2017

308

Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal

Mila Shakya, Rachel Colin-Jones, Katherine Theiss-Nyland,

New England Journal of Medicine

2019

184

Page 1